Veeva MedTech: Transforming Clinical Trials for Medical Technology Industry

The Transformation of Clinical Trials in MedTech

In a significant leap forward for the medical technology sector, Veeva Systems (NYSE: VEEV) has announced that it is now powering clinical applications for over 50 medical technology organizations. This includes 11 out of the top 20 companies in the industry as well as seven of the top 10 clinical research organizations. The adoption of Veeva’s clinical platform applications is a clear trend among medical device and diagnostic studies, as companies move away from traditional siloed solutions to modern, interconnected applications.

Addressing Industry Challenges

The impetus for this shift comes from increasing regulatory demands and an ever-evolving market landscape. Companies across sizes are finding that Veeva’s solutions provide the necessary scalability to manage a growing number of clinical trials while maintaining compliance with local, regional, and global regulations.

The efficiency gains are notable, with recent clients reporting up to 50% reductions in study development timelines thanks to Veeva EDC (Electronic Data Capture). Furthermore, firms have experienced a staggering 80% decrease in duplicate trial documentation through the implementation of Veeva eTMF (Electronic Trial Master File).

Kevin Liang, Vice President of Clinical Strategy at Veeva MedTech, expressed excitement over the industry’s pivot toward Veeva. “It’s thrilling to partner with an industry that is turning to Veeva MedTech for a comprehensive and connected infrastructure for clinical trials. We are collaborating with leading medical technology companies to enhance study execution, foster collaboration, and drive innovation to bring life-changing products to patients faster.”

Success Stories Within the MedTech Sector

The impact of Veeva’s platform can be illustrated through several success stories. Leianne Ebert, Head of Clinical Data Operations at Alcon, revealed their close collaboration with Veeva EDC to enhance their global library, focusing on reusable standards. This commitment to compliance has led to a remarkable 50% standardization in just one year.

Similarly, Kimberly Dorsch, Vice President of Global Clinical Affairs at LifeNet Health, noted the importance of consistent data collection. “Veeva helps us gather trial data in a manner that regulators will accept. Whether it’s a registry study or an IDE/IND study supporting a PMA/BLA submission, the data is collected consistently and adheres to regulations.”

Matt Christensen, Senior Vice President of Global Clinical and Medical Affairs at Smith+Nephew, shared his organization’s experience with Veeva eTMF. “Since deploying Veeva eTMF, we have reduced our quality control time by more than 90% and significantly cut down our document creation timelines.”

Conclusion

The medical technology industry is at a pivotal moment as it embraces tools like Veeva MedTech to streamline clinical trials, comply with regulations, and ultimately provide better products to patients. As more organizations adopt Veeva’s solutions, the landscape of clinical trials is set to change profoundly, paving the way for faster developments and innovations that could change lives.

For more information about Veeva’s clinical applications in the MedTech sector, visit veeva.com/MedTechClinical.